Terms: = Lymphoma AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990
26 results:
1. Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases.
Mundo L; Ambrosio MR; Raimondi F; Del Porro L; Guazzo R; Mancini V; Granai M; Jim Rocca B; Lopez C; Bens S; Onyango N; Nyagol J; Abinya N; Navari M; Ndede I; Patel K; Paolo Piccaluga P; Bob R; de Santi MM; Russell RB; Lazzi S; Siebert R; Stein H; Leoncini L
Blood Cancer J; 2019 Nov; 9(12):91. PubMed ID: 31748534
[TBL] [Abstract] [Full Text] [Related]
2. Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.
Schick M; Habringer S; Nilsson JA; Keller U
Br J Haematol; 2017 Dec; 179(5):724-738. PubMed ID: 29171017
[TBL] [Abstract] [Full Text] [Related]
3. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of lymphoma in Patients With Inflammatory Bowel Disease.
Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
[TBL] [Abstract] [Full Text] [Related]
4. Genetics of pleiotropic effects of dexamethasone.
Ramsey LB; Pounds S; Cheng C; Cao X; Yang W; Smith C; Karol SE; Liu C; Panetta JC; Inaba H; Rubnitz JE; Metzger ML; Ribeiro RC; Sandlund JT; Jeha S; Pui CH; Evans WE; Relling MV
Pharmacogenet Genomics; 2017 Aug; 27(8):294-302. PubMed ID: 28628558
[TBL] [Abstract] [Full Text] [Related]
5. A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.
Jung M; Russell AJ; Liu B; George J; Liu PY; Liu T; DeFazio A; Bowtell DD; Oberthuer A; London WB; Fletcher JI; Haber M; Norris MD; Henderson MJ
Cancer Res; 2017 Feb; 77(4):971-981. PubMed ID: 27923830
[TBL] [Abstract] [Full Text] [Related]
6. Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma.
Hoellein A; Fallahi M; Schoeffmann S; Steidle S; Schaub FX; Rudelius M; Laitinen I; Nilsson L; Goga A; Peschel C; Nilsson JA; Cleveland JL; Keller U
Blood; 2014 Sep; 124(13):2081-90. PubMed ID: 25143484
[TBL] [Abstract] [Full Text] [Related]
7. Small-cell lung cancers in patients who never smoked cigarettes.
Varghese AM; Zakowski MF; Yu HA; Won HH; Riely GJ; Krug LM; Kris MG; Rekhtman N; Ladanyi M; Wang L; Berger MF; Pietanza MC
J Thorac Oncol; 2014 Jun; 9(6):892-6. PubMed ID: 24828667
[TBL] [Abstract] [Full Text] [Related]
8. AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.
Zhong L; Shen H; Huang C; Jing H; Cao D
Toxicol Appl Pharmacol; 2011 Aug; 255(1):40-7. PubMed ID: 21640744
[TBL] [Abstract] [Full Text] [Related]
9. Chromosomal location targets different MYC family gene members for oncogenic translocations.
Gostissa M; Ranganath S; Bianco JM; Alt FW
Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2265-70. PubMed ID: 19174520
[TBL] [Abstract] [Full Text] [Related]
10. Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
Schwering I; Bräuninger A; Distler V; Jesdinsky J; Diehl V; Hansmann ML; Rajewsky K; Küppers R
Mol Med; 2003; 9(3-4):85-95. PubMed ID: 12865944
[TBL] [Abstract] [Full Text] [Related]
11. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.
Mao X; Orchard G; Lillington DM; Russell-Jones R; Young BD; Whittaker SJ
Blood; 2003 Feb; 101(4):1513-9. PubMed ID: 12393503
[TBL] [Abstract] [Full Text] [Related]
12. Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis.
Mao X; Lillington D; Child F; Russell-Jones R; Young B; Whittaker S
Genes Chromosomes Cancer; 2002 Oct; 35(2):144-55. PubMed ID: 12203778
[TBL] [Abstract] [Full Text] [Related]
13. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Kobzdej M; Matuszyk J; Strzadala L
Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
[TBL] [Abstract] [Full Text] [Related]
14. Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma.
Shou Y; Martelli ML; Gabrea A; Qi Y; Brents LA; Roschke A; Dewald G; Kirsch IR; Bergsagel PL; Kuehl WM
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):228-33. PubMed ID: 10618400
[TBL] [Abstract] [Full Text] [Related]
15. Restriction fragment length polymorphism of the L-myc oncogene in non-Hodgkin's lymphoma patients from India.
Fernandez T; Saranath D; Advani SH; Deo MG; Soman CS
Cancer Lett; 1998 Mar; 125(1-2):165-9. PubMed ID: 9566711
[TBL] [Abstract] [Full Text] [Related]
16. Activation of MYCN in a case of non-Hodgkin's lymphoma.
Finnegan MC; Hammond DW; Hancock BW; Goyns MH
Leuk Lymphoma; 1995 Aug; 18(5-6):511-4. PubMed ID: 8528061
[TBL] [Abstract] [Full Text] [Related]
17. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
[TBL] [Abstract] [Full Text] [Related]
18. Increased frequency of the S allele of the L-myc oncogene in non-Hodgkin's lymphoma.
Crossen PE; Morrison MJ; Colls BM
Br J Cancer; 1994 Apr; 69(4):759-61. PubMed ID: 7908219
[TBL] [Abstract] [Full Text] [Related]
19. L-myc and N-myc in hematopoietic malignancies.
Hirvonen H; Hukkanen V; Salmi TT; Pelliniemi TT; Alitalo R
Leuk Lymphoma; 1993 Oct; 11(3-4):197-205. PubMed ID: 8260894
[TBL] [Abstract] [Full Text] [Related]
20. Expression of myc-family genes in established human multiple myeloma cell lines: L-myc but not c-myc gene expression in the U-266 myeloma cell line.
Jernberg-Wiklund H; Pettersson M; Larsson LG; Anton R; Nilsson K
Int J Cancer; 1992 Apr; 51(1):116-23. PubMed ID: 1563831
[TBL] [Abstract] [Full Text] [Related]
[Next]